Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients
NCT ID: NCT06645002
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
144 participants
INTERVENTIONAL
2024-08-22
2025-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does stevia decrease the blood glucose level in diabetic subjects that will use stevia powder capsule? Does stevia play its role in blood lipid profile in diabetic subjects that will use stevia powder capsule? The purpose of the study to see the impact of stevia in short (7 days) and long-term treatments (60 days) in diabetic subjects and compare the results
Diabetic subjects will:
Take stevia powder capsule every day for 7 days in short term study Take stevia powder capsule every day for 60 days in long term study
Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 7th days in short term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 30 and 60th days in long term study Keep a record of all the tests for comparison
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Effects of Stevia in Type 2 Diabetic Patients
NCT02834715
Effects of Artificial Sweeteners on Glucose Metabolism in Patients With Type 2 Diabetes
NCT04185662
Nutrient Profiling and Bio-efficacy of Wheat-Barley Composite Flour in Type-2 Diabetes a in Randomized Control Clinical Trial
NCT04658264
Composite Flour and Its Antdiabetic Potential
NCT05163587
Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes Who Require Nutritional Support
NCT06632002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The balance diet plan will be prepared according to Pakistan dietary guidelines and given to all the study participants. Treatment stevia powder capsules will be provided to the participants for 7 days and for 60 days for short and long-term study respectively, for monitoring of compliance. Anthropometric measurements and biochemical assessments like blood glucose levels, lipid profile, insulin resistance and LFTs for short-term study will be measured at baseline, 7th and 60th day while, measurements of blood glucose, lipid profile, insulin resistance and LFTs will be carried out a baseline, 30, and 60 days for long-term study. In this research we will be analysed the effect of stevia powder capsules on diabetic patients for short and long term study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short term study
short term study (7 days) stevia leave powder 1000 mg/day
stevia rebaudiana bertoni
effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects
long term study
Long term study (60 days) stevia leave powder 1000 mg/day
stevia rebaudiana bertoni
effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects
stevia rebaudiana bertoni
effect of long term study (60 days) of stevia leave powder 1000 mg/day in diabetic subjects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stevia rebaudiana bertoni
effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects
stevia rebaudiana bertoni
effect of long term study (60 days) of stevia leave powder 1000 mg/day in diabetic subjects
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetic patients without anti-diabetic drugs and their duration of diabetes no longer than 6 months
* Diabetic patients with HbA1c \>6% and blood sugar level \>200 mg/dL
Exclusion Criteria
* Patients with nephropathy, retinopathy, diabetic foot, phenylketonuria, maple syrup urine disease
* Participants with acute and chronic kidney disease, kidney stone,
* Participants with history of acute liver injury (e.g., hepatitis) or severe cirrhosis
* Diabetic patients with obesity, cardiovascular diseases, pregnancy
* Participants taking nutritional supplements and other medicines
25 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allied Hospital Faisalabad
OTHER
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fasiha Ahsan
PhD scholar
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Allied Hospital Faisalabad
Faisalabad, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ritu M, Nandini J. Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. 2016 Sep;96(12):4231-4. doi: 10.1002/jsfa.7627. Epub 2016 Feb 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-UOL-FAHS/774/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.